Cognizance Biomarkers Overview
- Founded
-
2012
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Cognizance Biomarkers General Information
Description
Operator of a neurology and neuroinflammation-focused diagnostics company intended to achieve leadership in proteomic and genomic-based testing for improved diagnosis and treatment of neurological disorders, offering rapid, accurate and cost-effective precision medicine solutions for optimal patient outcomes. The company's diagnostic test identifies molecules that are indicative of these inflammation-induced seizures, enabling doctors to diagnose and treat people with non-epileptic seizures.
Contact Information
Website
www.cognizancebiomarkers.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Acquirer
Primary Office
- 3160 Chestnut Street
- Suite 200
- Philadelphia, PA 19104
- United States
Cognizance Biomarkers Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Jan-2015 | Completed | Startup | |||
| 3. Grant | 01-Jan-2015 | 00000 | Completed | Startup | ||
| 2. Accelerator/Incubator | 09-Apr-2013 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Cognizance Biomarkers Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Science Center | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| UPstart (Philadelphia) | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |